On July 13, 2018, GI Innovation, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,675 KRW | -0.56% | -35.23% | -54.74% |
2023 | Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS | CI |
2023 | Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers | CI |
1st Jan change | Capi. | |
---|---|---|
-54.74% | 59.26M | |
-41.39% | 8.27B | |
+3.25% | 3.35B | |
-0.37% | 2.34B | |
-19.19% | 2.02B | |
-22.57% | 1.62B | |
+32.82% | 1.16B | |
-8.30% | 713M | |
+14.12% | 696M | |
-31.22% | 488M |
- Stock Market
- Equities
- A180400 Stock
- News Dx & Vx Co., Ltd.
- GI Innovation, Inc. announced that it has received KRW 4.999995 billion in funding from Cancer Rop Co., Ltd.